The outcomes of these in silico approaches generate a precise and clear sense of the efficiency of known anti-tumor medicine by interacting with the Akt pathway and providing therapeutic efficacy.By interacting with the Akt pathway and giving therapeutic efficacy, the results of these in silico methodologies generate a precise and clear notion of the efficiency of the established antitumor medicine. This evidence concerns the gene AKT1 and neoplasm.